Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus

Jennifer Zelnick, Amrita Daftary, Christina Hwang, Amy S. Labar, Resha Boodhram, Bhavna Maharaj, Allison Wolf, Shinjini Mondal, K. Rivet Amico, Catherine Orrell, Boitumelo Seepamore, Gerald Friedland, Nesri Padayatchi, Max R. O’DonnellClinical 2020 · DOI

Abstract

EDM empirically identified a subpopulation of patients with DR-TB HIV with dual-adherence challenges early in treatment. Mixed-methods revealed intense psychosocial, behavioral, and structural barriers to care in this subpopulation. Our data support developing differential, patient-centered, adherence support interventions focused on psychosocial and structural challenges for subpopulations of at-risk DR-TB HIV patients.
BibTeX
@inproceedings{zelnick2020electronic,
  author = {Jennifer Zelnick and Amrita Daftary and Christina Hwang and Amy S. Labar and Resha Boodhram and Bhavna Maharaj and Allison Wolf and Shinjini Mondal and K. Rivet Amico and Catherine Orrell and Boitumelo Seepamore and Gerald Friedland and Nesri Padayatchi and Max R. O’Donnell},
  title = {{Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus}},
  booktitle = {Clinical},
  year = {2020},
  doi = {10.1093/cid/ciaa1557},
}

Loading related content...

Figure